Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award

April 18, 2011 By Bio-Medicine.Org

COVINGTON, Ky., April 18, 2011 /PRNewswire/ — Bexion
Pharmaceuticals was named the Biotech Innovation Award winner at
the Cincinnati USA Innovation Awards program sponsored by the
Cincinnati Business Courier, the Cincinnati USA Regional Chamber
and CincyTech.  The Innovation Awards celebrate outstanding
innovation and the companies and people who have shown how new
ideas can be developed into fuel for the regional Tri-State
(Ohio/Kentucky/Indiana) economic engine.

“The Bexion team is honored to be the very first winner of the
Biotech Innovation Award,” stated Dr. Ray Takigiku, co-founder and
CEO of Bexion.  “Cancer treatment and diagnosis is in dire
need of innovation.  We believe, and the award judges appear
to agree, that our approach represents an entirely new, exciting
and potentially paradigm-shifting approach to the treatment of
cancer.”

Bexion is developing BXQ-350 nanovesicles as a potential
treatment for the form of brain cancer called glioblastoma. 
BXQ-350 nanovesicles have an affinity for the membrane patches that
are common in many types of tumor cells including glioblastoma
cells. Bexion’s studies have shown effectiveness in the laboratory
in multiple animal tumor models, and across a remarkable range of
tumors in the test tube.

About Bexion Pharmaceuticals:Bexion Pharmaceuticals is
focused on the development and commercialization of innovative
cures for cancer.  Initial products are based on a
patent-protected and proprietary platform technology licensed from
Cincinnati Children’s Hospital Medical Center.  The technology
has demonstrated potential for development as therapeutics,
diagnostics and surgical imaging reagents, as well as carriers for
other pharmaceutical agents, such as oligonucleotides.  For
more information, visit www.bexionpharma.com.For
media enquiries contact:

For investor enquiries contact:Margaret van GilseChuck
Scheper

‘/>”/>

SOURCE

Related Articles Read More >

Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech